CTIS.eu › Cities › Netherlands › Hoofddorp
Hoofddorp
Netherlands
70 total trials
29 recruiting
2024-512975-11-01
11
urothelial cancer
2024-518821-13-00
4
Non-cystic Fibrosis Bronchiectasis
2024-519504-27-00
5
Relapsed Refractory Multiple Myeloma
2025-523117-28-00
4
Relapsed or Refractory Multiple Myeloma
2025-524191-38-00
6
Gallstones (chole(cysto)lithiasis) following bariatric surgery
2025-524229-41-00
5
Triple negative breast cancer
2025-521884-12-00
5
2026-03-19
First line triple-negative breast cancer (TNBC)
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
2023-507600-32-00
5
2025-05-22
Pneumococcal Immunization
2024-517410-15-01
5
2025-01-14
Rectal cancer
2023-507481-43-00
11
2024-06-25
Solid tumors
2022-502783-21-00
5
2024-02-20
B-Cell Non-Hodgkin's Lymphoma
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
2025-520927-26-00
5
2025-11-24
Metastatic Castration-resistant Prostate Cancer (mCRPC)
2024-520156-22-00
4
2025-10-08
Metastatic hormone-sensitive prostate cancer
2024-517051-12-00
4
2025-09-16
Relapsed primary large B-cel lymphoma of the central nervous system
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
2024-514850-59-00
5
2025-02-24
Appendicitis
2024-512950-13-00
11
2025-01-03
Sepsis
2023-506115-17-00
5
2024-10-14
Metastatic Colorectal Cancer
2024-514620-17-00
4
2024-10-14
Patients with early-stage rectal cancer (defined as early rectal cance
2023-505377-32-00
5
2024-08-15
Diffuse large B-cell lymphoma (DLBCL)
2024-513363-15-01
11
2024-07-22
(Chronic) Peripheral (occlusive) arterial disease (PAD)
Showing 1–24 of 70 trials